131 related articles for article (PubMed ID: 37658270)
1. Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules: A Large Study of 2022 Cases in China.
Yang X; Xiao Y; Hu H; Qiu ZB; Qi YF; Wang MM; Wu YL; Zhong WZ
Ann Surg Oncol; 2023 Nov; 30(12):7400-7411. PubMed ID: 37658270
[TBL] [Abstract][Full Text] [Related]
2. Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.
Rangachari D; VanderLaan PA; Shea M; Le X; Huberman MS; Kobayashi SS; Costa DB
J Thorac Oncol; 2017 May; 12(5):878-883. PubMed ID: 28104537
[TBL] [Abstract][Full Text] [Related]
3. Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity.
Si MJ; Tao XF; Du GY; Cai LL; Han HX; Liang XZ; Zhao JM
Eur J Radiol; 2016 Oct; 85(10):1708-1715. PubMed ID: 27666606
[TBL] [Abstract][Full Text] [Related]
4. Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non-small-cell lung cancer: The global, multicenter EXPRESS study.
Dietel M; Savelov N; Salanova R; Micke P; Bigras G; Hida T; Antunez J; Guldhammer Skov B; Hutarew G; Sua LF; Akita H; Chan OSH; Piperdi B; Burke T; Khambata-Ford S; Deitz AC
Lung Cancer; 2019 Aug; 134():174-179. PubMed ID: 31319978
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China.
Zheng Q; Huang Y; Zeng X; Chen X; Shao S; Jin Y; Xue Q; Wang Y; Guo Y; Gu B; Wu C; Li Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1547-1556. PubMed ID: 33196892
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements.
Yoneshima Y; Ijichi K; Anai S; Ota K; Otsubo K; Iwama E; Tanaka K; Oda Y; Nakanishi Y; Okamoto I
Lung Cancer; 2018 Apr; 118():36-40. PubMed ID: 29572000
[TBL] [Abstract][Full Text] [Related]
7. Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinoma.
Takamochi K; Hara K; Hayashi T; Kohsaka S; Takahashi F; Suehara Y; Suzuki K
Lung Cancer; 2021 Nov; 161():163-170. PubMed ID: 34600407
[TBL] [Abstract][Full Text] [Related]
8. Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells.
Cruz-Rico G; Avilés-Salas A; Popa-Navarro X; Lara-Mejía L; Catalán R; Sánchez-Reyes R; López-Sánchez D; Cabrera-Miranda L; Aquiles Maldonado-Martínez H; Samtani-Bassarmal S; Arrieta O
Pathol Oncol Res; 2021; 27():597499. PubMed ID: 34257548
[No Abstract] [Full Text] [Related]
9. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
[TBL] [Abstract][Full Text] [Related]
10. Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules.
Liu Y; Sun H; Zhou F; Su C; Gao G; Ren S; Zhou C; Zhang Z; Shi J
Lung Cancer; 2017 Jun; 108():192-197. PubMed ID: 28625634
[TBL] [Abstract][Full Text] [Related]
11. Relevance Between Programmed Death Ligand 1 and Radiologic Invasiveness in Pathologic Stage I Lung Adenocarcinoma.
Toyokawa G; Takada K; Okamoto T; Kawanami S; Kozuma Y; Matsubara T; Haratake N; Takamori S; Akamine T; Katsura M; Yamada Y; Shoji F; Baba S; Kamitani T; Oda Y; Honda H; Maehara Y
Ann Thorac Surg; 2017 Jun; 103(6):1750-1757. PubMed ID: 28347537
[TBL] [Abstract][Full Text] [Related]
12. [Value of CT Quantitative Parameters in Prediction of Pathological Types
of Lung Ground Glass Nodules].
Shi Y; Shen Y; Chen J; Yan W; Liu K
Zhongguo Fei Ai Za Zhi; 2024 Feb; 27(2):118-125. PubMed ID: 38453443
[TBL] [Abstract][Full Text] [Related]
13. Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma.
Chen P; Rojas FR; Hu X; Serrano A; Zhu B; Chen H; Hong L; Bandyoyadhyay R; Aminu M; Kalhor N; Lee JJ; El Hussein S; Khoury JD; Pass HI; Moreira AL; Velcheti V; Sterman DH; Fukuoka J; Tabata K; Su D; Ying L; Gibbons DL; Heymach JV; Wistuba II; Fujimoto J; Solis Soto LM; Zhang J; Wu J
Mod Pathol; 2023 Dec; 36(12):100326. PubMed ID: 37678674
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Expression in Chinese Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Multi-Center Retrospective Observational Study.
Yang X; Jiang L; Jin Y; Li P; Hou Y; Yun J; Wu C; Sun W; Fan X; Kuang D; Wang W; Ni J; Mao A; Tang W; Liu Z; Wang J; Xiao S; Li Y; Lin D
J Cancer; 2021; 12(24):7390-7398. PubMed ID: 35003359
[No Abstract] [Full Text] [Related]
15. Lung-PNet: An Automated Deep Learning Model for the Diagnosis of Invasive Adenocarcinoma in Pure Ground-Glass Nodules on Chest CT.
Qi K; Wang K; Wang X; Zhang YD; Lin G; Zhang X; Liu H; Huang W; Wu J; Zhao K; Liu J; Li J; Zhang X
AJR Am J Roentgenol; 2024 Jan; 222(1):e2329674. PubMed ID: 37493322
[No Abstract] [Full Text] [Related]
16. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
[TBL] [Abstract][Full Text] [Related]
17. Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib.
Yang CY; Liao WY; Ho CC; Chen KY; Tsai TH; Hsu CL; Liu YN; Su KY; Chang YL; Wu CT; Liao BC; Hsu CC; Hsu WH; Lee JH; Lin CC; Shih JY; Yang JC; Yu CJ
Oncologist; 2020 Aug; 25(8):702-711. PubMed ID: 32386255
[TBL] [Abstract][Full Text] [Related]
18. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.
Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S
Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309
[TBL] [Abstract][Full Text] [Related]
19. Solid histological component of adenocarcinoma might play an important role in PD-L1 expression of lung adenocarcinoma.
Miyazawa T; Morikawa K; Otsubo K; Sakai H; Kimura H; Chosokabe M; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
Thorac Cancer; 2022 Jan; 13(1):24-30. PubMed ID: 34811933
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
